Ion Channels: New Actors Playing in Chemotherapeutic Resistance

In the battle against cancer cells, therapeutic modalities are drastically limited by intrinsic or acquired drug resistance. Resistance to therapy is not only common, but expected: if systemic agents used for cancer treatment are usually active at the beginning of therapy (i.e., 90% of primary breas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Kischel, Philippe, Girault, Alban, Rodat-Despoix, Lise, Chamlali, Mohamed, Radoslavova, Silviya, Abou Daya, Hiba, Lefebvre, Thibaut, Foulon, Arthur, Rybarczyk, Pierre, Hague, Frédéric, Dhennin-Duthille, Isabelle, Gautier, Mathieu, Ouadid-Ahidouch, Halima
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6468599/
https://ncbi.nlm.nih.gov/pubmed/30884858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11030376
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars